<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2020-10-07" version="241">
<accession>Q01196</accession>
<accession>A8MV94</accession>
<accession>B2RMS4</accession>
<accession>D3DSG1</accession>
<accession>O60472</accession>
<accession>O60473</accession>
<accession>O76047</accession>
<accession>O76089</accession>
<accession>Q13081</accession>
<accession>Q13755</accession>
<accession>Q13756</accession>
<accession>Q13757</accession>
<accession>Q13758</accession>
<accession>Q13759</accession>
<accession>Q15341</accession>
<accession>Q15343</accession>
<accession>Q16122</accession>
<accession>Q16284</accession>
<accession>Q16285</accession>
<accession>Q16286</accession>
<accession>Q16346</accession>
<accession>Q16347</accession>
<accession>Q92479</accession>
<name>RUNX1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Runt-related transcription factor 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Acute myeloid leukemia 1 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Core-binding factor subunit alpha-2</fullName>
<shortName>CBF-alpha-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Oncogene AML-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Polyomavirus enhancer-binding protein 2 alpha B subunit</fullName>
<shortName>PEA2-alpha B</shortName>
<shortName>PEBP2-alpha B</shortName>
</alternativeName>
<alternativeName>
<fullName>SL3-3 enhancer factor 1 alpha B subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>SL3/AKV core-binding factor alpha B subunit</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RUNX1</name>
<name type="synonym">AML1</name>
<name type="synonym">CBFA2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1994-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Ahn M.-Y."/>
<person name="Bae S.C."/>
<person name="Zhang Y.W."/>
<person name="Shigesada K."/>
<person name="Ito Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="10431" last="10434">
<title>t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.</title>
<authorList>
<person name="Miyoshi H."/>
<person name="Shimizu K."/>
<person name="Kozu T."/>
<person name="Maseki N."/>
<person name="Kaneko Y."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="1720541"/>
<dbReference type="DOI" id="10.1073/pnas.88.23.10431"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM AML-1C)</scope>
<source>
<tissue>Leukocyte</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Genes Chromosomes Cancer" volume="11" first="226" last="236">
<title>AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts.</title>
<authorList>
<person name="Sacchi N."/>
<person name="Nisson P.E."/>
<person name="Watkins P.C."/>
<person name="Faustinella F."/>
<person name="Wijsman J."/>
<person name="Hagemeijer A."/>
</authorList>
<dbReference type="PubMed" id="7533526"/>
<dbReference type="DOI" id="10.1002/gcc.2870110405"/>
</citation>
<scope>ALTERNATIVE PRODUCTS</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH EAP</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1993" name="Blood" volume="81" first="2728" last="2734">
<title>Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis.</title>
<authorList>
<person name="Nucifora G."/>
<person name="Birn D.J."/>
<person name="Espinosa R. III"/>
<person name="Erickson P."/>
<person name="Lebeau M.M."/>
<person name="Roulston D."/>
<person name="McKeithan T.W."/>
<person name="Drabkin H."/>
<person name="Rowley J.D."/>
</authorList>
<dbReference type="PubMed" id="8490181"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM AML-1E)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH ETO</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1994" name="Genomics" volume="23" first="425" last="432">
<title>AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization.</title>
<authorList>
<person name="Levanon D."/>
<person name="Negreanu V."/>
<person name="Bernstein Y."/>
<person name="Bar-Am I."/>
<person name="Avivi L."/>
<person name="Groner Y."/>
</authorList>
<dbReference type="PubMed" id="7835892"/>
<dbReference type="DOI" id="10.1006/geno.1994.1519"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM AML-1A)</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="Nucleic Acids Res." volume="23" first="2762" last="2769">
<title>Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia.</title>
<authorList>
<person name="Miyoshi H."/>
<person name="Ohira M."/>
<person name="Shimizu K."/>
<person name="Mitani K."/>
<person name="Hirai H."/>
<person name="Imai T."/>
<person name="Yokoyama K."/>
<person name="Soeda E."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="7651838"/>
<dbReference type="DOI" id="10.1093/nar/23.14.2762"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS AML-1B; AML-1A; AML-1G AND AML-1L)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="1974" last="1982">
<title>The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation.</title>
<authorList>
<person name="Meyers S."/>
<person name="Lenny N."/>
<person name="Hiebert S.W."/>
</authorList>
<dbReference type="PubMed" id="7891692"/>
<dbReference type="DOI" id="10.1128/mcb.15.4.1974"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM AML-1G)</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="4133" last="4145">
<title>A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells.</title>
<authorList>
<person name="Zhang Y.-W."/>
<person name="Bae S.-C."/>
<person name="Huang G."/>
<person name="Fu Y.-X."/>
<person name="Lu J."/>
<person name="Ahn M.-Y."/>
<person name="Kanno Y."/>
<person name="Kanno T."/>
<person name="Ito Y."/>
</authorList>
<dbReference type="PubMed" id="9199349"/>
<dbReference type="DOI" id="10.1128/mcb.17.7.4133"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM AML-1L)</scope>
<scope>FUNCTION (ISOFORM AML-1L)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Nature" volume="405" first="311" last="319">
<title>The DNA sequence of human chromosome 21.</title>
<authorList>
<person name="Hattori M."/>
<person name="Fujiyama A."/>
<person name="Taylor T.D."/>
<person name="Watanabe H."/>
<person name="Yada T."/>
<person name="Park H.-S."/>
<person name="Toyoda A."/>
<person name="Ishii K."/>
<person name="Totoki Y."/>
<person name="Choi D.-K."/>
<person name="Groner Y."/>
<person name="Soeda E."/>
<person name="Ohki M."/>
<person name="Takagi T."/>
<person name="Sakaki Y."/>
<person name="Taudien S."/>
<person name="Blechschmidt K."/>
<person name="Polley A."/>
<person name="Menzel U."/>
<person name="Delabar J."/>
<person name="Kumpf K."/>
<person name="Lehmann R."/>
<person name="Patterson D."/>
<person name="Reichwald K."/>
<person name="Rump A."/>
<person name="Schillhabel M."/>
<person name="Schudy A."/>
<person name="Zimmermann W."/>
<person name="Rosenthal A."/>
<person name="Kudoh J."/>
<person name="Shibuya K."/>
<person name="Kawasaki K."/>
<person name="Asakawa S."/>
<person name="Shintani A."/>
<person name="Sasaki T."/>
<person name="Nagamine K."/>
<person name="Mitsuyama S."/>
<person name="Antonarakis S.E."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Nordsiek G."/>
<person name="Hornischer K."/>
<person name="Brandt P."/>
<person name="Scharfe M."/>
<person name="Schoen O."/>
<person name="Desario A."/>
<person name="Reichelt J."/>
<person name="Kauer G."/>
<person name="Bloecker H."/>
<person name="Ramser J."/>
<person name="Beck A."/>
<person name="Klages S."/>
<person name="Hennig S."/>
<person name="Riesselmann L."/>
<person name="Dagand E."/>
<person name="Wehrmeyer S."/>
<person name="Borzym K."/>
<person name="Gardiner K."/>
<person name="Nizetic D."/>
<person name="Francis F."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Yaspo M.-L."/>
</authorList>
<dbReference type="PubMed" id="10830953"/>
<dbReference type="DOI" id="10.1038/35012518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM AML-1G)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="504" last="510">
<title>Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.</title>
<authorList>
<person name="Mitani K."/>
<person name="Ogawa S."/>
<person name="Tanaka T."/>
<person name="Miyoshi H."/>
<person name="Kurokawa M."/>
<person name="Mano H."/>
<person name="Yazaki Y."/>
<person name="Ohki M."/>
<person name="Hirai H."/>
</authorList>
<dbReference type="PubMed" id="8313895"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1994.tb06288.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-177</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH MECOM IN CHRONIC MYELOCYTIC LEUKEMIA</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="1935" last="1940">
<title>Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions.</title>
<authorList>
<person name="Ghozi M.C."/>
<person name="Bernstein Y."/>
<person name="Negreanu V."/>
<person name="Levanon D."/>
<person name="Groner Y."/>
</authorList>
<dbReference type="PubMed" id="8700862"/>
<dbReference type="DOI" id="10.1073/pnas.93.5.1935"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-90 (ISOFORMS AML-1H AND AML-1I)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="DNA Cell Biol." volume="15" first="175" last="185">
<title>A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1.</title>
<authorList>
<person name="Levanon D."/>
<person name="Bernstein Y."/>
<person name="Negreanu V."/>
<person name="Ghozi M.C."/>
<person name="Bar-Am I."/>
<person name="Aloya R."/>
<person name="Goldenberg D."/>
<person name="Lotem J."/>
<person name="Groner Y."/>
</authorList>
<dbReference type="PubMed" id="8634147"/>
<dbReference type="DOI" id="10.1089/dna.1996.15.175"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 440-453</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="15">
<citation type="submission" date="1998-05" db="EMBL/GenBank/DDBJ databases">
<title>Sequencing and analysis of 960 kb between AML1 and CBR1 on chromosome 21q22.2.</title>
<authorList>
<person name="Blechschmidt K."/>
<person name="Rump A."/>
<person name="Nordsiek G."/>
<person name="Drescher B."/>
<person name="Weber J."/>
<person name="Rosenthal A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-19</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM AML-1G)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1992" name="Nature" volume="356" first="484" last="484">
<title>Leukaemia/Drosophila homology.</title>
<authorList>
<person name="Daga A."/>
<person name="Tighe J.E."/>
<person name="Calabi F."/>
</authorList>
<dbReference type="PubMed" id="1560822"/>
<dbReference type="DOI" id="10.1038/356484b0"/>
</citation>
<scope>SIMILARITY TO RUNT</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="6336" last="6345">
<title>Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions.</title>
<authorList>
<person name="Meyers S."/>
<person name="Downing J.R."/>
<person name="Hiebert S.W."/>
</authorList>
<dbReference type="PubMed" id="8413232"/>
<dbReference type="DOI" id="10.1128/mcb.13.10.6336"/>
</citation>
<scope>ENHANCER CORE BINDING SEQUENCE</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="640" last="653">
<title>ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.</title>
<authorList>
<person name="Bruhn L."/>
<person name="Munnerlyn A."/>
<person name="Grosschedl R."/>
</authorList>
<dbReference type="PubMed" id="9119228"/>
<dbReference type="DOI" id="10.1101/gad.11.5.640"/>
</citation>
<scope>INTERACTION WITH ALYREF/THOC4</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1998" name="Blood" volume="91" first="4028" last="4037">
<title>The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family.</title>
<authorList>
<person name="Gamou T."/>
<person name="Kitamura E."/>
<person name="Hosoda F."/>
<person name="Shimuzu K."/>
<person name="Hayashi Y."/>
<person name="Nagase T."/>
<person name="Yokoyama Y."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="9596646"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH CBFA2T3</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="11590" last="11595">
<title>Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.</title>
<authorList>
<person name="Levanon D."/>
<person name="Goldstein R.E."/>
<person name="Bernstein Y."/>
<person name="Tang H."/>
<person name="Goldenberg D."/>
<person name="Stifani S."/>
<person name="Paroush Z."/>
<person name="Groner Y."/>
</authorList>
<dbReference type="PubMed" id="9751710"/>
<dbReference type="DOI" id="10.1073/pnas.95.20.11590"/>
</citation>
<scope>INTERACTION WITH TLE1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="3635" last="3644">
<title>Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias.</title>
<authorList>
<person name="Mao S."/>
<person name="Frank R.C."/>
<person name="Zhang J."/>
<person name="Miyazaki Y."/>
<person name="Nimer S.D."/>
</authorList>
<dbReference type="PubMed" id="10207087"/>
<dbReference type="DOI" id="10.1128/mcb.19.5.3635"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ELF1; ELF2; ELF4 AND SPI1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="7184" last="7196">
<title>Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.</title>
<authorList>
<person name="Kitabayashi I."/>
<person name="Aikawa Y."/>
<person name="Nguyen L.A."/>
<person name="Yokoyama A."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="11742995"/>
<dbReference type="DOI" id="10.1093/emboj/20.24.7184"/>
</citation>
<scope>INTERACTION WITH KAT6A</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="2729" last="2740">
<title>MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2.</title>
<authorList>
<person name="Pelletier N."/>
<person name="Champagne N."/>
<person name="Stifani S."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="11965546"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205367"/>
</citation>
<scope>INTERACTION WITH KAT6B</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="5229" last="5237">
<title>SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.</title>
<authorList>
<person name="Chakraborty S."/>
<person name="Sinha K.K."/>
<person name="Senyuk V."/>
<person name="Nucifora G."/>
</authorList>
<dbReference type="PubMed" id="12917624"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206600"/>
</citation>
<scope>INTERACTION WITH SUV39H1</scope>
<scope>METHYLATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="19512" last="19522">
<title>Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene.</title>
<authorList>
<person name="Cho J.-Y."/>
<person name="Akbarali Y."/>
<person name="Zerbini L.F."/>
<person name="Gu X."/>
<person name="Boltax J."/>
<person name="Wang Y."/>
<person name="Oettgen P."/>
<person name="Zhang D.-E."/>
<person name="Libermann T.A."/>
</authorList>
<dbReference type="PubMed" id="14970218"/>
<dbReference type="DOI" id="10.1074/jbc.m309074200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ELF2</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="5777" last="5786">
<title>RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription.</title>
<authorList>
<person name="Reed-Inderbitzin E."/>
<person name="Moreno-Miralles I."/>
<person name="Vanden-Eynden S.K."/>
<person name="Xie J."/>
<person name="Lutterbach B."/>
<person name="Durst-Goodwin K.L."/>
<person name="Luce K.S."/>
<person name="Irvin B.J."/>
<person name="Cleary M.L."/>
<person name="Brandt S.J."/>
<person name="Hiebert S.W."/>
</authorList>
<dbReference type="PubMed" id="16652147"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209591"/>
</citation>
<scope>INTERACTION WITH SUV39H1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="2361" last="2370">
<title>Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.</title>
<authorList>
<person name="Fujimoto T."/>
<person name="Anderson K."/>
<person name="Jacobsen S.E."/>
<person name="Nishikawa S.I."/>
<person name="Nerlov C."/>
</authorList>
<dbReference type="PubMed" id="17431401"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601675"/>
</citation>
<scope>FUNCTION IN MYELOID DIFFERENTIATION</scope>
<scope>INTERACTION WITH CDK6</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Eur. J. Haematol." volume="79" first="25" last="31">
<title>LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22).</title>
<authorList>
<person name="Imagama S."/>
<person name="Abe A."/>
<person name="Suzuki M."/>
<person name="Hayakawa F."/>
<person name="Katsumi A."/>
<person name="Emi N."/>
<person name="Kiyoi H."/>
<person name="Naoe T."/>
</authorList>
<dbReference type="PubMed" id="17532767"/>
<dbReference type="DOI" id="10.1111/j.1600-0609.2007.00858.x"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MACROD1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Nature" volume="446" first="685" last="689">
<title>Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.</title>
<authorList>
<person name="Ono M."/>
<person name="Yaguchi H."/>
<person name="Ohkura N."/>
<person name="Kitabayashi I."/>
<person name="Nagamura Y."/>
<person name="Nomura T."/>
<person name="Miyachi Y."/>
<person name="Tsukada T."/>
<person name="Sakaguchi S."/>
</authorList>
<dbReference type="PubMed" id="17377532"/>
<dbReference type="DOI" id="10.1038/nature05673"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXP3</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Blood" volume="112" first="3777" last="3787">
<title>PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.</title>
<authorList>
<person name="Wee H.-J."/>
<person name="Voon D.C.-C."/>
<person name="Bae S.-C."/>
<person name="Ito Y."/>
</authorList>
<dbReference type="PubMed" id="18695000"/>
<dbReference type="DOI" id="10.1182/blood-2008-01-134122"/>
</citation>
<scope>PHOSPHORYLATION AT SER-249; THR-273 AND SER-276 BY HIPK2</scope>
<scope>VARIANT GLN-174</scope>
<scope>MUTAGENESIS OF SER-67; LYS-83; GLY-108; SER-249; THR-273 AND SER-276</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="350" last="361">
<title>Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage.</title>
<authorList>
<person name="Levy D."/>
<person name="Adamovich Y."/>
<person name="Reuven N."/>
<person name="Shaul Y."/>
</authorList>
<dbReference type="PubMed" id="18280240"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.12.022"/>
</citation>
<scope>INTERACTION WITH YAP1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND SER-21</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="2853" last="2858">
<title>Transforming activity of AML1-ETO is independent of CBFbeta and ETO interaction but requires formation of homo-oligomeric complexes.</title>
<authorList>
<person name="Kwok C."/>
<person name="Zeisig B.B."/>
<person name="Qiu J."/>
<person name="Dong S."/>
<person name="So C.W."/>
</authorList>
<dbReference type="PubMed" id="19202074"/>
<dbReference type="DOI" id="10.1073/pnas.0810558106"/>
</citation>
<scope>INTERACTION WITH CBFB</scope>
<scope>MUTAGENESIS OF MET-106; ALA-107 AND SER-140</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; SER-249; SER-266; SER-268 AND SER-276</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-24 AND LYS-43</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Leukemia" volume="24" first="1516" last="1519">
<title>CBFA2T2 and C20orf112: two novel fusion partners of RUNX1 in acute myeloid leukemia.</title>
<authorList>
<person name="Guastadisegni M.C."/>
<person name="Lonoce A."/>
<person name="Impera L."/>
<person name="Di Terlizzi F."/>
<person name="Fugazza G."/>
<person name="Aliano S."/>
<person name="Grasso R."/>
<person name="Cluzeau T."/>
<person name="Raynaud S."/>
<person name="Rocchi M."/>
<person name="Storlazzi C.T."/>
</authorList>
<dbReference type="PubMed" id="20520637"/>
<dbReference type="DOI" id="10.1038/leu.2010.106"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH CBFA2T2</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; SER-21; SER-193; SER-212 AND THR-296</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212 AND SER-435</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="Cell. Mol. Life Sci." volume="72" first="821" last="832">
<title>Novel function of PITH domain-containing 1 as an activator of internal ribosomal entry site to enhance RUNX1 expression and promote megakaryocyte differentiation.</title>
<authorList>
<person name="Lu B."/>
<person name="Sun X."/>
<person name="Chen Y."/>
<person name="Jin Q."/>
<person name="Liang Q."/>
<person name="Liu S."/>
<person name="Li Y."/>
<person name="Zhou Y."/>
<person name="Li W."/>
<person name="Huang Z."/>
</authorList>
<dbReference type="PubMed" id="25134913"/>
<dbReference type="DOI" id="10.1007/s00018-014-1704-2"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2000" name="EMBO J." volume="19" first="3004" last="3015">
<title>Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta.</title>
<authorList>
<person name="Warren A.J."/>
<person name="Bravo J."/>
<person name="Williams R.L."/>
<person name="Rabbitts T.H."/>
</authorList>
<dbReference type="PubMed" id="10856244"/>
<dbReference type="DOI" id="10.1093/emboj/19.12.3004"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 59-173 IN COMPLEX WITH CBFB</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="371" last="378">
<title>The leukemia-associated AML1 (Runx1) -- CBF beta complex functions as a DNA-induced molecular clamp.</title>
<authorList>
<person name="Bravo J."/>
<person name="Li Z."/>
<person name="Speck N.A."/>
<person name="Warren A.J."/>
</authorList>
<dbReference type="PubMed" id="11276260"/>
<dbReference type="DOI" id="10.1038/86264"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 54-243 IN COMPLEX WITH CBFB AND DNA</scope>
<scope>MUTAGENESIS OF ARG-80; LYS-83; THR-84; ARG-135; ARG-139; ARG-142; LYS-167; THR-169; ASP-171; ARG-174 AND ARG-177</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2002" name="Structure" volume="10" first="1395" last="1407">
<title>DNA recognition by the RUNX1 transcription factor is mediated by an allosteric transition in the RUNT domain and by DNA bending.</title>
<authorList>
<person name="Bartfeld D."/>
<person name="Shimon L."/>
<person name="Couture G.C."/>
<person name="Rabinovich D."/>
<person name="Frolow F."/>
<person name="Levanon D."/>
<person name="Groner Y."/>
<person name="Shakked Z."/>
</authorList>
<dbReference type="PubMed" id="12377125"/>
<dbReference type="DOI" id="10.1016/s0969-2126(02)00853-5"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 61-174 IN COMPLEX WITH DNA</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1999" name="Nat. Struct. Biol." volume="6" first="615" last="619">
<title>Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.</title>
<authorList>
<person name="Nagata T."/>
<person name="Gupta V."/>
<person name="Sorce D."/>
<person name="Kim W.-Y."/>
<person name="Sali A."/>
<person name="Chait B.T."/>
<person name="Shigesada K."/>
<person name="Ito Y."/>
<person name="Werner M.H."/>
</authorList>
<dbReference type="PubMed" id="10404214"/>
<dbReference type="DOI" id="10.1038/10658"/>
</citation>
<scope>STRUCTURE BY NMR OF 53-178</scope>
<scope>MUTAGENESIS OF ALA-107 AND GLY-108</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1999" name="Structure" volume="7" first="1247" last="1256">
<title>The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains.</title>
<authorList>
<person name="Berardi M.J."/>
<person name="Sun C."/>
<person name="Zehr M."/>
<person name="Abildgaard F."/>
<person name="Peng J."/>
<person name="Speck N.A."/>
<person name="Bushweller J.H."/>
</authorList>
<dbReference type="PubMed" id="10545320"/>
<dbReference type="DOI" id="10.1016/s0969-2126(00)80058-1"/>
</citation>
<scope>STRUCTURE BY NMR OF 61-175 IN COMPLEX WITH DNA</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2002" name="J. Mol. Biol." volume="322" first="259" last="272">
<title>The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.</title>
<authorList>
<person name="Baeckstroem S."/>
<person name="Wolf-Watz M."/>
<person name="Grundstroem C."/>
<person name="Haerd T."/>
<person name="Grundstroem T."/>
<person name="Sauer U.H."/>
</authorList>
<dbReference type="PubMed" id="12217689"/>
<dbReference type="DOI" id="10.1016/s0022-2836(02)00702-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 46-185</scope>
<scope>CHLORIDE-BINDING</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1995" name="Blood" volume="86" first="1" last="14">
<title>AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia.</title>
<authorList>
<person name="Nucifora G."/>
<person name="Rowley J.D."/>
</authorList>
<dbReference type="PubMed" id="7795214"/>
</citation>
<scope>REVIEW ON AML1 TRANSLOCATIONS</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1992" name="Cancer Genet. Cytogenet." volume="63" first="81" last="88">
<title>Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells.</title>
<authorList>
<person name="Nisson P.E."/>
<person name="Watkins P.C."/>
<person name="Sacchi N."/>
</authorList>
<dbReference type="PubMed" id="1423235"/>
<dbReference type="DOI" id="10.1016/0165-4608(92)90384-k"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MTG8/ETO IN AML-M2</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1993" name="Blood" volume="82" first="1270" last="1276">
<title>Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.</title>
<authorList>
<person name="Kozu T."/>
<person name="Miyoshi H."/>
<person name="Shimizu K."/>
<person name="Maseki N."/>
<person name="Kaneko Y."/>
<person name="Asou H."/>
<person name="Kamada N."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="8353289"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MTG8/ETO IN AML-M2</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1993" name="EMBO J." volume="12" first="2715" last="2721">
<title>The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.</title>
<authorList>
<person name="Miyoshi H."/>
<person name="Kozu T."/>
<person name="Shimizu K."/>
<person name="Enomoto K."/>
<person name="Maseki N."/>
<person name="Kaneko Y."/>
<person name="Kamada N."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="8334990"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1993.tb05933.x"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MTG8/ETO IN AML-M2</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="7784" last="7788">
<title>The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.</title>
<authorList>
<person name="Nucifora G."/>
<person name="Begy C.R."/>
<person name="Erickson P."/>
<person name="Drabkin H.A."/>
<person name="Rowley J.D."/>
</authorList>
<dbReference type="PubMed" id="8395054"/>
<dbReference type="DOI" id="10.1073/pnas.90.16.7784"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH EAP IN MYELODYSPLASIA</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="1994" name="Blood" volume="84" first="2115" last="2121">
<title>Alternative, out-of-frame runt/MTG8 transcripts are encoded by the derivative (8) chromosome in the t(8;21) of acute myeloid leukemia M2.</title>
<authorList>
<person name="Tighe J.E."/>
<person name="Calabi F."/>
</authorList>
<dbReference type="PubMed" id="7919324"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MTG8/ETO IN AML-M2</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1995" name="Blood" volume="85" first="3662" last="3670">
<title>The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.</title>
<authorList>
<person name="Romana S.P."/>
<person name="Mauchauffe M."/>
<person name="le Coniat M."/>
<person name="Chumakov I."/>
<person name="le Paslier D."/>
<person name="Berger R."/>
<person name="Bernard O.A."/>
</authorList>
<dbReference type="PubMed" id="7780150"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TEL IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1995" name="Genes Chromosomes Cancer" volume="13" first="25" last="33">
<title>Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.</title>
<authorList>
<person name="Era T."/>
<person name="Asou N."/>
<person name="Kunisada T."/>
<person name="Yamasaki H."/>
<person name="Asou H."/>
<person name="Kamada N."/>
<person name="Nishikawa S."/>
<person name="Yamaguchi K."/>
<person name="Takatsuki K."/>
</authorList>
<dbReference type="PubMed" id="7541640"/>
<dbReference type="DOI" id="10.1002/gcc.2870130105"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MTG8/ETO IN AML-M2</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="4917" last="4921">
<title>Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.</title>
<authorList>
<person name="Golub T.R."/>
<person name="Barker G.F."/>
<person name="Bohlander S.K."/>
<person name="Hiebert S.W."/>
<person name="Ward D.C."/>
<person name="Bray-Ward P."/>
<person name="Morgan E."/>
<person name="Raimondi S.C."/>
<person name="Rowley J.D."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="7761424"/>
<dbReference type="DOI" id="10.1073/pnas.92.11.4917"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TEL IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="166" last="175">
<title>Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.</title>
<authorList>
<person name="Song W.-J."/>
<person name="Sullivan M.G."/>
<person name="Legare R.D."/>
<person name="Hutchings S."/>
<person name="Tan X."/>
<person name="Kufrin D."/>
<person name="Ratajczak J."/>
<person name="Resende I.C."/>
<person name="Haworth C."/>
<person name="Hock R."/>
<person name="Loh M."/>
<person name="Felix C."/>
<person name="Roy D.-C."/>
<person name="Busque L."/>
<person name="Kurnit D."/>
<person name="Willman C."/>
<person name="Gewirtz A.M."/>
<person name="Speck N.A."/>
<person name="Bushweller J.H."/>
<person name="Li F.P."/>
<person name="Gardiner K."/>
<person name="Poncz M."/>
<person name="Maris J.M."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="10508512"/>
<dbReference type="DOI" id="10.1038/13793"/>
</citation>
<scope>VARIANTS FPDMM GLN-139 AND GLN-174</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="BMC Cancer" volume="8" first="299" last="299">
<title>Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.</title>
<authorList>
<person name="Gelsi-Boyer V."/>
<person name="Trouplin V."/>
<person name="Adelaide J."/>
<person name="Aceto N."/>
<person name="Remy V."/>
<person name="Pinson S."/>
<person name="Houdayer C."/>
<person name="Arnoulet C."/>
<person name="Sainty D."/>
<person name="Bentires-Alj M."/>
<person name="Olschwang S."/>
<person name="Vey N."/>
<person name="Mozziconacci M.-J."/>
<person name="Birnbaum D."/>
<person name="Chaffanet M."/>
</authorList>
<dbReference type="PubMed" id="18925961"/>
<dbReference type="DOI" id="10.1186/1471-2407-8-299"/>
</citation>
<scope>CHROMOSOMAL REARRANGEMENT</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2017" name="Proc. Natl. Acad. Sci. U.S.A." volume="114" first="6016" last="6021">
<title>Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.</title>
<authorList>
<person name="Huber F.M."/>
<person name="Greenblatt S.M."/>
<person name="Davenport A.M."/>
<person name="Martinez C."/>
<person name="Xu Y."/>
<person name="Vu L.P."/>
<person name="Nimer S.D."/>
<person name="Hoelz A."/>
</authorList>
<dbReference type="PubMed" id="28533407"/>
<dbReference type="DOI" id="10.1073/pnas.1700328114"/>
</citation>
<scope>INTERACTION WITH DPF2</scope>
</reference>
<comment type="function">
<text evidence="11 13 20 23 25 26 43">Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. The heterodimers bind to the core site of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters (Probable). Essential for the development of normal hematopoiesis (PubMed:17431401). Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the BLK promoter (PubMed:10207087, PubMed:14970218). Inhibits KAT6B-dependent transcriptional activation (By similarity). Involved in lineage commitment of immature T cell precursors. CBF complexes repress ZBTB7B transcription factor during cytotoxic (CD8+) T cell development. They bind to RUNX-binding sequence within the ZBTB7B locus acting as transcriptional silencer and allowing for cytotoxic T cell differentiation. CBF complexes binding to the transcriptional silencer is essential for recruitment of nuclear protein complexes that catalyze epigenetic modifications to establish epigenetic ZBTB7B silencing (By similarity). Controls the anergy and suppressive function of regulatory T-cells (Treg) by associating with FOXP3. Activates the expression of IL2 and IFNG and down-regulates the expression of TNFRSF18, IL2RA and CTLA4, in conventional T-cells (PubMed:17377532). Positively regulates the expression of RORC in T-helper 17 cells (By similarity).</text>
</comment>
<comment type="function">
<text evidence="11">Isoform AML-1G shows higher binding activities for target genes and binds TCR-beta-E2 and RAG-1 target site with threefold higher affinity than other isoforms. It is less effective in the context of neutrophil terminal differentiation.</text>
</comment>
<comment type="function">
<text evidence="34">Isoform AML-1L interferes with the transactivation activity of RUNX1.</text>
</comment>
<comment type="subunit">
<text evidence="11 13 16 17 18 19 20 21 22 23 24 25 26 27 32 33 35">Heterodimer with CBFB. RUNX1 binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Isoform AML-1L can neither bind DNA nor heterodimerize. Interacts with TLE1 and ALYREF/THOC4 (PubMed:9119228, PubMed:9751710). Interacts with ELF1, ELF2 and SPI1 (PubMed:10207087). Interacts via its Runt domain with the ELF4 N-terminal region (PubMed:10207087). Interaction with ELF2 isoform 2 (NERF-1a) may act to repress RUNX1-mediated transactivation (PubMed:14970218). Interacts with KAT6A and KAT6B (PubMed:11742995, PubMed:11965546). Interacts with SUV39H1, leading to abrogation of transactivating and DNA-binding properties of RUNX1 (PubMed:12917624, PubMed:16652147). Interacts with YAP1 (PubMed:18280240). Interacts with HIPK2 (By similarity). Interaction with CDK6 prevents myeloid differentiation, reducing its transcription transactivation activity. Found in a complex with PRMT5, RUNX1 and CBFB. Interacts with FOXP3 (PubMed:17377532). Interacts with TBX21 (By similarity). Interacts with DPF2 (PubMed:28533407).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925904">
<id>Q01196</id>
</interactant>
<interactant intactId="EBI-718750">
<id>Q13951</id>
<label>CBFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925904">
<id>Q01196</id>
</interactant>
<interactant intactId="EBI-295663">
<id>Q00534</id>
<label>CDK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925904">
<id>Q01196</id>
</interactant>
<interactant intactId="EBI-956941">
<id>Q15723</id>
<label>ELF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925904">
<id>Q01196</id>
</interactant>
<interactant intactId="EBI-348345">
<id>Q9H2X6</id>
<label>HIPK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925904">
<id>Q01196</id>
</interactant>
<interactant intactId="EBI-912511">
<id>P52926</id>
<label>HMGA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925904">
<id>Q01196</id>
</interactant>
<interactant intactId="EBI-1753878">
<id>P17542</id>
<label>TAL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925904">
<id>Q01196</id>
</interactant>
<interactant intactId="EBI-1044059">
<id>P46937</id>
<label>YAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925940">
<id>Q01196-1</id>
</interactant>
<interactant intactId="EBI-711424">
<id>Q04724</id>
<label>TLE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925940">
<id>Q01196-1</id>
</interactant>
<interactant intactId="EBI-25489004">
<id>P59633</id>
<label>3b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925940">
<id>Q01196-1</id>
</interactant>
<interactant intactId="EBI-153866">
<id>P16371</id>
<label>gro</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-925944">
<id>Q01196-2</id>
</interactant>
<interactant intactId="EBI-711424">
<id>Q04724</id>
<label>TLE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-747185">
<id>O95817</id>
<label>BAG3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-2949658">
<id>O95429</id>
<label>BAG4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-718750">
<id>Q13951</id>
<label>CBFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-12010594">
<id>O75909-2</id>
<label>CCNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-2807642">
<id>Q8WU58</id>
<label>FAM222B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-2510157">
<id>Q96EF6</id>
<label>FBXO17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-746252">
<id>Q96CN9</id>
<label>GCC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-740220">
<id>O14964</id>
<label>HGS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-10271199">
<id>Q8NI38</id>
<label>NFKBID</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-10225049">
<id>Q7RTU3</id>
<label>OLIG3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-766589">
<id>P09234</id>
<label>SNRPC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-9370956">
<id>Q15562-2</id>
<label>TEAD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-747736">
<id>Q15561</id>
<label>TEAD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-10239812">
<id>Q96M29</id>
<label>TEKT5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12001422">
<id>Q01196-8</id>
</interactant>
<interactant intactId="EBI-2559305">
<id>A5D8V6</id>
<label>VPS37C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q01196-1</id>
<name>AML-1B</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q01196-2</id>
<name>AML-1A</name>
<sequence type="described" ref="VSP_005929"/>
</isoform>
<isoform>
<id>Q01196-3</id>
<name>AML-1C</name>
<sequence type="described" ref="VSP_005926 VSP_005927"/>
</isoform>
<isoform>
<id>Q01196-4</id>
<name>AML-1E</name>
<sequence type="described" ref="VSP_005928"/>
</isoform>
<isoform>
<id>Q01196-5</id>
<name>AML-1FA</name>
<sequence type="described" ref="VSP_005923 VSP_005924"/>
</isoform>
<isoform>
<id>Q01196-6</id>
<name>AML-1FB</name>
<sequence type="described" ref="VSP_005921 VSP_005922"/>
</isoform>
<isoform>
<id>Q01196-7</id>
<name>AML-1FC</name>
<sequence type="described" ref="VSP_005920 VSP_005925"/>
</isoform>
<isoform>
<id>Q01196-8</id>
<name>AML-1G</name>
<sequence type="described" ref="VSP_005917"/>
</isoform>
<isoform>
<id>Q01196-9</id>
<name>AML-1H</name>
<sequence type="described" ref="VSP_005916"/>
</isoform>
<isoform>
<id>Q01196-10</id>
<name>AML-1I</name>
<sequence type="described" ref="VSP_005918"/>
</isoform>
<isoform>
<id>Q01196-11</id>
<name>AML-1L</name>
<name>AML1-delta N</name>
<sequence type="described" ref="VSP_005919"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text>Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.</text>
</comment>
<comment type="induction">
<text evidence="31">Up-regulated by phorbol myristate acetate (PMA).</text>
</comment>
<comment type="domain">
<text>A proline/serine/threonine rich region at the C-terminus is necessary for transcriptional activation of target genes.</text>
</comment>
<comment type="PTM">
<text>Phosphorylated in its C-terminus upon IL-6 treatment. Phosphorylation enhances interaction with KAT6A.</text>
</comment>
<comment type="PTM">
<text evidence="22">Methylated.</text>
</comment>
<comment type="PTM">
<text evidence="28">Phosphorylated in Ser-249 Thr-273 and Ser-276 by HIPK2 when associated with CBFB and DNA. This phosphorylation promotes subsequent EP300 phosphorylation.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving RUNX1/AML1 is a cause of M2 type acute myeloid leukemia (AML-M2). Translocation t(8;21)(q22;q22) with RUNX1T1.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving RUNX1/AML1 is a cause of therapy-related myelodysplastic syndrome (T-MDS). Translocation t(3;21)(q26;q22) with EAP or MECOM.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein.</text>
</comment>
<comment type="disease" evidence="15">
<disease id="DI-01597">
<name>Familial platelet disorder with associated myeloid malignancy</name>
<acronym>FPDMM</acronym>
<description>Autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.</description>
<dbReference type="MIM" id="601399"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.</text>
</comment>
<comment type="disease">
<text evidence="30">A chromosomal aberration involving RUNX1/AML1 is found in acute myeloid leukemia. Translocation t(20;21)(q11;q22) with CBFA2T2.</text>
</comment>
<comment type="caution">
<text evidence="43">The fusion of AML1 with EAP in T-MDS induces a change of reading frame in the latter resulting in 17 AA unrelated to those of EAP.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAC05246" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="43">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAC05247" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/AML1ID52.html"/>
</comment>
<dbReference type="EMBL" id="L34598">
<property type="protein sequence ID" value="AAA51720.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D43967">
<property type="protein sequence ID" value="BAA07902.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D10570">
<property type="protein sequence ID" value="BAA01426.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S76345">
<property type="protein sequence ID" value="AAB33729.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S76346">
<property type="protein sequence ID" value="AAB33730.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S76350">
<property type="protein sequence ID" value="AAB33731.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S60998">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X79549">
<property type="protein sequence ID" value="CAA56092.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D43968">
<property type="protein sequence ID" value="BAA07903.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D43969">
<property type="protein sequence ID" value="BAA07904.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U19601">
<property type="protein sequence ID" value="AAB51691.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L21756">
<property type="protein sequence ID" value="AAA03086.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S69002">
<property type="protein sequence ID" value="AAB29907.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D13979">
<property type="protein sequence ID" value="BAA03089.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D14822">
<property type="protein sequence ID" value="BAA03559.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D14823">
<property type="protein sequence ID" value="BAA03560.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S78158">
<property type="protein sequence ID" value="AAB34819.2"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S78159">
<property type="protein sequence ID" value="AAB34820.2"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S50186">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S78496">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S74092">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X90979">
<property type="protein sequence ID" value="CAA62466.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X90976">
<property type="protein sequence ID" value="CAA62464.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D89790">
<property type="protein sequence ID" value="BAA14022.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D89788">
<property type="protein sequence ID" value="BAA14020.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D89789">
<property type="protein sequence ID" value="BAA14021.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000330">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000331">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000332">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000333">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000334">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF015262">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09769.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09770.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136380">
<property type="protein sequence ID" value="AAI36381.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136381">
<property type="protein sequence ID" value="AAI36382.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC144053">
<property type="protein sequence ID" value="AAI44054.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF025841">
<property type="protein sequence ID" value="AAC05246.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF025841">
<property type="protein sequence ID" value="AAC05247.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ229043">
<property type="protein sequence ID" value="CAA13070.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13639.1">
<molecule id="Q01196-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42922.1">
<molecule id="Q01196-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46646.1">
<molecule id="Q01196-3"/>
</dbReference>
<dbReference type="PIR" id="I39443">
<property type="entry name" value="I39443"/>
</dbReference>
<dbReference type="PIR" id="S57842">
<property type="entry name" value="S57842"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001001890.1">
<molecule id="Q01196-1"/>
<property type="nucleotide sequence ID" value="NM_001001890.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001116079.1">
<molecule id="Q01196-3"/>
<property type="nucleotide sequence ID" value="NM_001122607.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001745.2">
<molecule id="Q01196-8"/>
<property type="nucleotide sequence ID" value="NM_001754.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005261125.1">
<molecule id="Q01196-10"/>
<property type="nucleotide sequence ID" value="XM_005261068.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528068.1">
<molecule id="Q01196-8"/>
<property type="nucleotide sequence ID" value="XM_011529766.2"/>
</dbReference>
<dbReference type="PDB" id="1CMO">
<property type="method" value="NMR"/>
<property type="chains" value="A=52-178"/>
</dbReference>
<dbReference type="PDB" id="1CO1">
<property type="method" value="NMR"/>
<property type="chains" value="A=61-175"/>
</dbReference>
<dbReference type="PDB" id="1E50">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C/E/G/Q/R=50-183"/>
</dbReference>
<dbReference type="PDB" id="1H9D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C=50-183"/>
</dbReference>
<dbReference type="PDB" id="1LJM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=51-181"/>
</dbReference>
<dbReference type="PDBsum" id="1CMO"/>
<dbReference type="PDBsum" id="1CO1"/>
<dbReference type="PDBsum" id="1E50"/>
<dbReference type="PDBsum" id="1H9D"/>
<dbReference type="PDBsum" id="1LJM"/>
<dbReference type="SMR" id="Q01196"/>
<dbReference type="BioGRID" id="107309">
<property type="interactions" value="234"/>
</dbReference>
<dbReference type="CORUM" id="Q01196"/>
<dbReference type="DIP" id="DIP-36773N"/>
<dbReference type="ELM" id="Q01196"/>
<dbReference type="IntAct" id="Q01196">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="MINT" id="Q01196"/>
<dbReference type="STRING" id="9606.ENSP00000300305"/>
<dbReference type="GlyGen" id="Q01196">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q01196"/>
<dbReference type="MetOSite" id="Q01196"/>
<dbReference type="PhosphoSitePlus" id="Q01196"/>
<dbReference type="BioMuta" id="RUNX1"/>
<dbReference type="DMDM" id="215274205"/>
<dbReference type="EPD" id="Q01196"/>
<dbReference type="jPOST" id="Q01196"/>
<dbReference type="MassIVE" id="Q01196"/>
<dbReference type="MaxQB" id="Q01196"/>
<dbReference type="PaxDb" id="Q01196"/>
<dbReference type="PeptideAtlas" id="Q01196"/>
<dbReference type="PRIDE" id="Q01196"/>
<dbReference type="ProteomicsDB" id="57927">
<molecule id="Q01196-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57928">
<molecule id="Q01196-10"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57929">
<molecule id="Q01196-11"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57930">
<molecule id="Q01196-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57931">
<molecule id="Q01196-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57932">
<molecule id="Q01196-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57933">
<molecule id="Q01196-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57934">
<molecule id="Q01196-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57935">
<molecule id="Q01196-7"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57936">
<molecule id="Q01196-8"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57937">
<molecule id="Q01196-9"/>
</dbReference>
<dbReference type="Antibodypedia" id="935">
<property type="antibodies" value="1057 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000300305">
<molecule id="Q01196-8"/>
<property type="protein sequence ID" value="ENSP00000300305"/>
<property type="gene ID" value="ENSG00000159216"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000344691">
<molecule id="Q01196-1"/>
<property type="protein sequence ID" value="ENSP00000340690"/>
<property type="gene ID" value="ENSG00000159216"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000358356">
<molecule id="Q01196-3"/>
<property type="protein sequence ID" value="ENSP00000351123"/>
<property type="gene ID" value="ENSG00000159216"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000437180">
<molecule id="Q01196-8"/>
<property type="protein sequence ID" value="ENSP00000409227"/>
<property type="gene ID" value="ENSG00000159216"/>
</dbReference>
<dbReference type="GeneID" id="861"/>
<dbReference type="KEGG" id="hsa:861"/>
<dbReference type="UCSC" id="uc002yuh.3">
<molecule id="Q01196-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="861"/>
<dbReference type="DisGeNET" id="861"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000159216.18"/>
<dbReference type="GeneCards" id="RUNX1"/>
<dbReference type="HGNC" id="HGNC:10471">
<property type="gene designation" value="RUNX1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000159216">
<property type="expression patterns" value="Tissue enhanced (breast, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="RUNX1"/>
<dbReference type="MIM" id="151385">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="601399">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q01196"/>
<dbReference type="OpenTargets" id="ENSG00000159216"/>
<dbReference type="Orphanet" id="102724">
<property type="disease" value="Acute myeloid leukemia with t(8;21)(q22;q22) translocation"/>
</dbReference>
<dbReference type="Orphanet" id="98850">
<property type="disease" value="Aggressive systemic mastocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="521">
<property type="disease" value="Chronic myeloid leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="71290">
<property type="disease" value="Familial platelet disorder with associated myeloid malignancy"/>
</dbReference>
<dbReference type="Orphanet" id="248340">
<property type="disease" value="Isolated delta-storage pool disease"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34884"/>
<dbReference type="eggNOG" id="KOG3982">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159255"/>
<dbReference type="HOGENOM" id="CLU_032910_1_0_1"/>
<dbReference type="InParanoid" id="Q01196"/>
<dbReference type="KO" id="K08367"/>
<dbReference type="OMA" id="PRVNHST"/>
<dbReference type="OrthoDB" id="562214at2759"/>
<dbReference type="PhylomeDB" id="Q01196"/>
<dbReference type="TreeFam" id="TF321496"/>
<dbReference type="PathwayCommons" id="Q01196"/>
<dbReference type="Reactome" id="R-HSA-1912408">
<property type="pathway name" value="Pre-NOTCH Transcription and Translation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-549127">
<property type="pathway name" value="Organic cation transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8877330">
<property type="pathway name" value="RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8931987">
<property type="pathway name" value="RUNX1 regulates estrogen receptor mediated transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8934593">
<property type="pathway name" value="Regulation of RUNX1 Expression and Activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8935964">
<property type="pathway name" value="RUNX1 regulates expression of components of tight junctions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8936459">
<property type="pathway name" value="RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939236">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of HSCs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939242">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of keratinocytes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939243">
<property type="pathway name" value="RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939245">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in BCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939246">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of myeloid cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939247">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in interleukin signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939256">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in WNT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941333">
<property type="pathway name" value="RUNX2 regulates genes involved in differentiation of myeloid cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951936">
<property type="pathway name" value="RUNX3 regulates p14-ARF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9616222">
<property type="pathway name" value="Transcriptional regulation of granulopoiesis"/>
</dbReference>
<dbReference type="SignaLink" id="Q01196"/>
<dbReference type="SIGNOR" id="Q01196"/>
<dbReference type="BioGRID-ORCS" id="861">
<property type="hits" value="36 hits in 896 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RUNX1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q01196"/>
<dbReference type="GeneWiki" id="RUNX1"/>
<dbReference type="GenomeRNAi" id="861"/>
<dbReference type="Pharos" id="Q01196">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q01196"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 21"/>
</dbReference>
<dbReference type="RNAct" id="Q01196">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000159216">
<property type="expression patterns" value="Expressed in epithelium of mammary gland and 207 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q01196">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q01196">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016513">
<property type="term" value="C:core-binding factor complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002062">
<property type="term" value="P:chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071425">
<property type="term" value="P:hematopoietic stem cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043371">
<property type="term" value="P:negative regulation of CD4-positive, alpha-beta T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030853">
<property type="term" value="P:negative regulation of granulocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001503">
<property type="term" value="P:ossification"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048935">
<property type="term" value="P:peripheral nervous system neuron development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043378">
<property type="term" value="P:positive regulation of CD8-positive, alpha-beta T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030854">
<property type="term" value="P:positive regulation of granulocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032743">
<property type="term" value="P:positive regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050855">
<property type="term" value="P:regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:2000810">
<property type="term" value="P:regulation of bicellular tight junction assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045595">
<property type="term" value="P:regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001959">
<property type="term" value="P:regulation of cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1902036">
<property type="term" value="P:regulation of hematopoietic stem cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033146">
<property type="term" value="P:regulation of intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045616">
<property type="term" value="P:regulation of keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045652">
<property type="term" value="P:regulation of megakaryocyte differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045637">
<property type="term" value="P:regulation of myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045589">
<property type="term" value="P:regulation of regulatory T cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030111">
<property type="term" value="P:regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.720">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.770.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000040">
<property type="entry name" value="AML1_Runt"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR012346">
<property type="entry name" value="p53/RUNT-type_TF_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013524">
<property type="entry name" value="Runt_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027384">
<property type="entry name" value="Runx_central_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013711">
<property type="entry name" value="RunxI_C_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016554">
<property type="entry name" value="TF_Runt-rel_RUNX"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11950">
<property type="entry name" value="PTHR11950"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00853">
<property type="entry name" value="Runt"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08504">
<property type="entry name" value="RunxI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF009374">
<property type="entry name" value="TF_Runt-rel_RUNX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00967">
<property type="entry name" value="ONCOGENEAML1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51062">
<property type="entry name" value="RUNT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0868">Chloride</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="Runt-related transcription factor 1" id="PRO_0000174655">
<location>
<begin position="1"/>
<end position="453"/>
</location>
</feature>
<feature type="domain" description="Runt" evidence="12">
<location>
<begin position="50"/>
<end position="178"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="80"/>
<end position="84"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="135"/>
<end position="143"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="168"/>
<end position="177"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with KAT6A" evidence="19">
<location>
<begin position="291"/>
<end position="371"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with KAT6B" evidence="10">
<location>
<begin position="307"/>
<end position="400"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FOXP3" evidence="25">
<location>
<begin position="362"/>
<end position="402"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro/Ser/Thr-rich">
<location>
<begin position="187"/>
<end position="453"/>
</location>
</feature>
<feature type="binding site" description="Chloride 1">
<location>
<position position="112"/>
</location>
</feature>
<feature type="binding site" description="Chloride 1; via amide nitrogen">
<location>
<position position="116"/>
</location>
</feature>
<feature type="binding site" description="Chloride 2">
<location>
<position position="139"/>
</location>
</feature>
<feature type="binding site" description="Chloride 2; via amide nitrogen">
<location>
<position position="170"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form AML1-EMV-1 (or AML1-EAP) in CML and T-MDS, to form AML1-MTG8 (ETO) in AML-M2, to form AML1-CBFA2T3 in therapy-related myeloid malignancies, to form AML1-MECOM in CML and to form type I MACROD1-RUNX1 fusion protein">
<location>
<begin position="177"/>
<end position="178"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form AML1-EAP in T-MDS and CML, to form type II MACROD1-RUNX1 fusion protein and to form RUNX1-CBFA2T2 in acute myeloid leukemia" evidence="30">
<location>
<begin position="241"/>
<end position="242"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 7 8">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="6">
<location>
<position position="24"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="6">
<location>
<position position="43"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="193"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="212"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by HIPK2" evidence="7 28">
<location>
<position position="249"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="266"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="268"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by HIPK2" evidence="28">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by HIPK2" evidence="7 28">
<location>
<position position="276"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="296"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="435"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1L." id="VSP_005919" evidence="38 42">
<location>
<begin position="1"/>
<end position="105"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1G." id="VSP_005917" evidence="36 38 40">
<original>MRIPV</original>
<variation>MASDSIFESFPSYPQCFMRECILGMNPSRDVH</variation>
<location>
<begin position="1"/>
<end position="5"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1H." id="VSP_005916" evidence="43">
<original>MRIPV</original>
<variation>MNPSRDVH</variation>
<location>
<begin position="1"/>
<end position="5"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1I." id="VSP_005918" evidence="43">
<original>MRIPV</original>
<variation>MPAAPRGPAQGEAAARTRSR</variation>
<location>
<begin position="1"/>
<end position="5"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1FC." id="VSP_005920" evidence="43">
<original>VGRSGRGKSFTLTITVFTNPPQVATYHRAIKITVDGPREPRRHRQKLDDQTKPGSLSFSERLSELEQLRRTAMRVSPHHPAPTPNPRASLNHSTAFNPQPQSQMQD</original>
<variation>VDGPREPRRHRQKLDDQTKPGSLSFSERLSELEQLRRTAMRVSPHHPAPTPNPRASLNHSTAFNPQPQSQMQDTRQIQPSPPWSYDQSYQYLGSIASPSVHPATPI</variation>
<location>
<begin position="137"/>
<end position="242"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1FA." id="VSP_005923" evidence="43">
<original>RHRQKLDDQTKPGSLSFSERLSELEQLRRTAMRVSPHHPAPTPNPRA</original>
<variation>SKCIHLGLVHPPGWYTLQAGILRDHVSDSLGSTFPPGGWQAPVKPKS</variation>
<location>
<begin position="178"/>
<end position="224"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1FB." id="VSP_005921" evidence="43">
<original>RHRQKLDDQTK</original>
<variation>NSLTWPRYPHI</variation>
<location>
<begin position="178"/>
<end position="188"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1FB." id="VSP_005922" evidence="43">
<location>
<begin position="189"/>
<end position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1FA." id="VSP_005924" evidence="43">
<location>
<begin position="225"/>
<end position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1C." id="VSP_005926" evidence="37">
<original>DTRQIQPSP</original>
<variation>EEDTAPWRC</variation>
<location>
<begin position="242"/>
<end position="250"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1FC." id="VSP_005925" evidence="43">
<location>
<begin position="243"/>
<end position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1C." id="VSP_005927" evidence="37">
<location>
<begin position="251"/>
<end position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1E." id="VSP_005928" evidence="41">
<location>
<begin position="258"/>
<end position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform AML-1A." id="VSP_005929" evidence="38 39">
<original>APSARLEEAVWRPY</original>
<variation>GGASCSRQARRDPGPWARTPSWGRGRPTDRISL</variation>
<location>
<begin position="440"/>
<end position="453"/>
</location>
</feature>
<feature type="sequence variant" description="In FPDMM; dbSNP:rs1060499616." id="VAR_012128" evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In FPDMM; impaired phosphorylation; dbSNP:rs74315450." id="VAR_012129" evidence="15 28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1055308." id="VAR_013177">
<original>S</original>
<variation>R</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1055309." id="VAR_013178">
<original>S</original>
<variation>R</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of heterodimerization and reduced EP300 phosphorylation induction." evidence="28">
<original>S</original>
<variation>R</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18 28">
<original>K</original>
<variation>A</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding, impaired phosphorylation and reduced EP300 phosphorylation induction." evidence="18 28">
<original>K</original>
<variation>E</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on DNA binding." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction of AML1-MTG8/ETO with CBFB, no effect on AML1-MTG8/ETO-mediated transformation activity." evidence="29">
<original>M</original>
<variation>V</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of heterodimerization. Disrupts interactionof AML1-MTG8/ETO with CBFB, no effect on AML1-MTG8/ETO-mediated transformation activity." evidence="14 29">
<original>A</original>
<variation>T</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of heterodimerization and impaired phosphorylation." evidence="14 28">
<original>G</original>
<variation>R</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts AML1-MTG8/ETO DNA-binding, decreases AML1-MTG8/ETO transforming activity." evidence="29">
<original>S</original>
<variation>G</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="mutagenesis site" description="No DNA-binding.">
<location>
<begin position="145"/>
<end position="453"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces DNA-binding." evidence="18">
<original>K</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces DNA-binding." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="28">
<original>S</original>
<variation>A</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation; when associated with A-276." evidence="28">
<original>T</original>
<variation>A</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation; when associated with A-273." evidence="28">
<original>S</original>
<variation>A</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51720." ref="1" evidence="43">
<original>S</original>
<variation>F</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="54"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="70"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="77"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="82"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="90"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="102"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="110"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="117"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="121"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="128"/>
<end position="130"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="146"/>
<end position="152"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="158"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="166"/>
<end position="171"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CMO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1E50"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1H9D"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1LJM"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q03347"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00399"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10207087"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10404214"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10508512"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10545320"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10856244"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11276260"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11742995"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11965546"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12377125"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12917624"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14970218"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16652147"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17377532"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17431401"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18280240"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18695000"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19202074"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20520637"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25134913"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28533407"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9119228"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9199349"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9751710"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1720541"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7651838"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7835892"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7891692"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8490181"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9199349"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000305"/>
<sequence length="453" mass="48737" checksum="4F1F193A7CADDBAB" modified="2008-11-25" version="3">MRIPVDASTSRRFTPPSTALSPGKMSEALPLGAPDAGAALAGKLRSGDRSMVEVLADHPGELVRTDSPNFLCSVLPTHWRCNKTLPIAFKVVALGDVPDGTLVTVMAGNDENYSAELRNATAAMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKITVDGPREPRRHRQKLDDQTKPGSLSFSERLSELEQLRRTAMRVSPHHPAPTPNPRASLNHSTAFNPQPQSQMQDTRQIQPSPPWSYDQSYQYLGSIASPSVHPATPISPGRASGMTTLSAELSSRLSTAPDLTAFSDPRQFPALPSISDPRMHYPGAFTYSPTPVTSGIGIGMSAMGSATRYHTYLPPPYPGSSQAQGGPFQASSPSYHLYYGASAGSYQFSMVGGERSPPRILPPCTNASTGSALLNPSLPNQSDVVEAEGSHSNSPTNMAPSARLEEAVWRPY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

